lATEST BLOG POSTS
Good Faith Exams for PRP Hair Restoration (2026 Guide)
Good faith exams for PRP hair restoration need an in-person physician sign-off. See what to look for, top picks, and what to avoid in 2026.
Medical Director for PDO Thread Lift Providers (2026)
Medical director for PDO thread lift providers in 2026: what to look for, top coverage options, and what to avoid before treating your next patient.
Medical Director for TRT Clinics: 2026 Buying Guide
Compare medical director options for TRT clinics in 2026 — what to look for, top picks, and what to avoid before you prescribe testosterone.
Medical Director for PRP Hair Restoration Clinics 2026
Medical director for PRP hair restoration clinics in 2026: good faith exams, collaborating physician agreements, and verdicts for each clinic type in the U.S.
Medical Director for Tattoo Removal Clinics (2026 Guide)
Find the right medical director for tattoo removal clinics in 2026: compliance criteria, coverage models, and a clear buy/skip verdict for each option.
Medical Director for Ketamine Clinics: 2026 Buying Guide
What a medical director for ketamine clinics needs to cover in 2026 — chart review, good faith exams, DEA compliance, and which oversight models to skip.
Collaborating Physician for Ohio NPs: Buy or Skip in 2026
Ohio nurse practitioners need a collaborating physician under state law. Compare 2026 program options, coverage models, and red flags before you sign an SCA.
Collaborating Physician for Massachusetts NPs 2026 Guide
Massachusetts NPs running injectables need a collaborating physician that survives a board audit. Compare the 2026 models and see which one wins for medspas.
Collaborating Physician for WA Nurse Practitioners (2026)
Compare collaborating physician options for Washington nurse practitioners in 2026: costs, turnaround, and the safe pick versus what to skip.
Medical Director for CoolSculpting Clinics: 2026 Guide
Compare medical director models for CoolSculpting and body contouring clinics in 2026 — coverage types, good faith exam cadence, and a clear buy/skip verdict.










